FRET Imaging of Enzyme-Responsive HPMA Copolymer Conjugate.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Macromolecular Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/mabi.201600125PMID 27198936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluorescence optical imaging in anticancer drug delivery.

  2016cited by this paper
• Surgical molecular navigation with ratiometric activatable cell penetrating peptide for intraoperative identification and resection of small salivary gland cancers

  2016cited by this paper
• FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapy.

  2015cited by this paper
• Matrix-Metalloproteinases in Head and Neck Carcinoma–Cancer Genome Atlas Analysis and Fluorescence Imaging in Mice

  2014cited by this paper
• Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates

  2014cited by this paper
• Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.

  2013cited by this paper
• Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.

  2013cited by this paper
• Polymer-drug conjugates: origins, progress to date and future directions.

  2013cited by this paper
• Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats.

  2013cited by this paper
• Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy.

  2013cited by this paper
• Biological rationale for the design of polymeric anti-cancer nanomedicines

  2013cited by this paper
• Backbone degradable multiblock N-(2-hydroxypropyl)methacrylamide copolymer conjugates via reversible addition-fragmentation chain transfer polymerization and thiol-ene coupling reaction.

  2011cited by this paper
• Synthesis of Biodegradable Multiblock Copolymers by Click Coupling of RAFT-Generated HeterotelechelicPolyHPMA Conjugates.

  2011cited by this paper
• Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice.

  2011cited by this paper
• Biodegradable Multiblock Poly[N-(2-hydroxypropyl)methacrylamide] via Reversible Addition-Fragmentation Chain Transfer Polymerization and Click Chemistry.

  2011cited by this paper
• HPMA copolymers: origins, early developments, present, and future.

  2010cited by this paper
• Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

  2009cited by this paper
• Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells

  2009cited by this paper
• Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities*

  2006cited by this paper
• Synthesis and properties of new N-(2-hydroxypropyl)methacrylamide copolymers containing thiazolidine-2-thione reactive groups

  2006cited by this paper
• Cathepsins B and D Activity and Activity Ratios in Normal Ovaries, Benign Ovarian Neoplasms, and Epithelial Ovarian Cancer

  2005cited by this paper
• Looking and listening to light: the evolution of whole-body photonic imaging

  2005cited by this paper
• The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.

  2004cited by this paper
• FRET imaging

  2003cited by this paper
• Determination of Cathepsin B Expression May Offer Additional Prognostic Information for Ovarian Cancer Patients

  2002cited by this paper
• Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

  1999cited by this paper
• Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC).

  1995cited by this paper
• Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters.

  1995cited by this paper
• Prognostic value of increased lung tumor tissue cathepsin B.

  1994cited by this paper
• Protease activities in gastric cancer tissues.

  1990cited by this paper
• Cathepsin B and cystatins: evidence for a role in cancer progression.

  1990cited by this paper
• Polymers containing enzymatically degradable bonds, 8. Degradation of oligopeptide sequences in N‐(2‐hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B

  1983cited by this paper
• Lysosomal cathepsin B: correlation with metastatic potential.

  1981cited by this paper
• Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization

  1973cited by this paper

• Exploring therapeutic and diagnostic potential of cysteine cathepsin as targets for cancer therapy with nanomedicine.

  2025cites this paper
• Ratiometric near-infrared fluorescent probe for nitroreductase activity enables 3D imaging of hypoxic cells within intact tumor spheroids

  2024cites this paper
• A molecular beacon-assisted nanotheranostic agent for real-time detection and effective combined management of acquired resistance to EGFR-TKIs

  2023cites this paper
• Polyglutamate-based nanoconjugates for image-guided surgery and post-operative melanoma metastases prevention

  2022cites this paper
• Harnessing Endogenous Stimuli for Responsive Materials in Theranostics

  2021cites this paper
• Escaping the endosome: Assessing cellular trafficking mechanisms of non-viral vehicles.

  2021cites this paper
• Cathepsin B-responsive nanodrug delivery systems for precise diagnosis and targeted therapy of malignant tumors

  2020cites this paper
• Application of Fluorescence in Studying Therapeutic Enzymes.

  2019cites this paper
• Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases.

  2019cites this paper
• Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors

  2019cites this paper
• Glutathione responsive poly(HPMA) conjugate nanoparticles for efficient 6-MP delivery

  2019cites this paper
• Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment

  2019cites this paper
• FRET Monitoring of Intracellular Ketal Hydrolysis in Synthetic Nanoparticles.

  2018cites this paper
• Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins

  2018cites this paper
• Förster‐Resonanzenergietransfer‐basierter Nachweis intrazellulärer Ketal‐Hydrolyse in synthetisch vernetzten Nanopartikeln

  2018cites this paper
• Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines.

  2017cites this paper
• Dual-sensitive and biodegradable core-crosslinked HPMA copolymer–doxorubicin conjugate-based nanoparticles for cancer therapy

  2017cites this paper
• Peptide-Drug Conjugate: A Novel Drug Design Approach.

  2017cites this paper
• A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting.

  2017cites this paper